Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
How Is the Diabetes Care Market Size Expected to Evolve From 2025 to 2029?
The diabetes care market size has grown strongly in recent years. It will grow from $26.79 billion in 2024 to $29.09 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising obesity rates, growing demand for continuous monitoring devices, growing investment in diabetes research and development, and rising demand for personalized diabetes care.
The diabetes care market size is expected to see strong growth in the next few years. It will grow to " $40.55 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing prevalence of diabetes, a growing geriatric population, rising awareness of diabetes management, and increasing healthcare access in developing regions. Major trends in the forecast period include technological advancements in diabetes monitoring, integration of artificial intelligence (AI) in diabetes care, advancements in insulin delivery systems, and development of smart insulin devices.
Get your free report sample today:
Which Primary Drivers Are Expected to Shape the Future of the Diabetes Care Market?
The increasing obesity rates are expected to propel the growth of the diabetes care market going forward. Obesity rates refer to the percentage of a population with a body mass index (BMI) of 30 or higher, indicating obesity. The increasing obesity rates are due to a growing reliance on sedentary lifestyles, coupled with the widespread availability and consumption of highly processed, calorie-dense foods that are often low in nutritional value, contributing to an imbalance between calorie intake and physical activity. Diabetes care plays a crucial role in addressing rising obesity rates by promoting healthier lifestyle choices, improving glucose management, and encouraging weight control through advanced treatments such as insulin therapy and continuous glucose monitoring systems. For instance, in March 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2022, 390 million adults were underweight, while 2.5 billion adults were overweight, including 890 million individuals considered obese. Therefore, the increasing obesity rates are driving the growth of the diabetes care market.
How Is the Diabetes Care Market Categorized Based on Key Segments?
The diabetes caremarket covered in this report is segmented –
1) By Product Type: Glucose Monitoring Devices; Insulin Pumps; Other Product Types
2) By Diabetes Type: Type 2 Diabetes; Type 1 Diabetes; Other Diabetes Type
3) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Care Settings; Other End Users
Subsegments:
1) By Glucose Monitoring Devices: Blood glucose monitoring (BGM); Continuous glucose monitoring (CGM); Flash glucose monitoring (FGM)
2) By Insulin Pumps: Patch pump; Tethered pump; Implanted insulin pump
Which Emerging Trends Are Shaping the Future of the Diabetes Care Market?
Major companies operating in the diabetes care market are focusing on developing innovative technologies, such as automated insulin delivery (AID) systems, to improve glucose management by integrating continuous glucose monitoring (CGM) systems with insulin pumps for real-time adjustments. An Automated Insulin Delivery (AID) system is a technology that combines a Continuous Glucose Monitor (CGM) with an insulin pump to automatically adjust insulin delivery based on real-time glucose levels for improved diabetes management. For instance, in February 2024, Tandem Diabetes Care Inc., a US-based manufacturer of medical equipment for diabetes treatment, introduced the Tandem Mobi, the smallest and most robust automated insulin administration device for diabetics in the world. This innovative device offers a discreet, tubed insulin pump that is fully controllable via a smartphone app, giving users the freedom to manage their diabetes without the need for a traditional handheld controller. The Tandem Mobi is waterproof and rechargeable, and it integrates with Dexcom’s continuous glucose monitoring (CGM) system to automate insulin delivery using Tandem’s proven Control-IQ technology.
Who Are the Established and Emerging Companies Competing in the Diabetes Care Market?
Major companies operating in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.
Get the detailed diabetes care market report today
Which Region Is Expected to Dominate the Diabetes Care Market During the Forecast Period?
North America was the largest region in the diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment